Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...

In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...

The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and ...

Bone metastases from pancreatic tumors are rare, representing less than 5% of all metastases [ 2 ]. Among these, only three ...

The American Cancer Society’s 2026 Cancer Statistics report shows the five-year survival rate for all cancers has reached a ...

Gene that drops early in pancreatic tumors linked to shorter survival at stage II. Findings could guide future treatment ...

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the ...

Enhanced chemosensitivity: Laboratory data suggest PRP makes resistant pancreatic tumor cells more responsive to standard chemotherapies and alters the tumor microenvironment — including reduced ...

Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.

According to the American Cancer Society’s new annual report, 70% of Americans with cancer are alive at least five years ...